BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11453958)

  • 1. Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women.
    Seck T; Scheidt-Nave C; Leidig-Bruckner G; Ziegler R; Pfeilschifter J
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):101-6. PubMed ID: 11453958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.
    Gillberg P; Olofsson H; Mallmin H; Blum WF; Ljunghall S; Nilsson AG
    Calcif Tissue Int; 2002 Jan; 70(1):22-9. PubMed ID: 11907704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
    Vestergaard P; Hermann AP; Orskov H; Mosekilde L
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2286-90. PubMed ID: 10404791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study.
    Barrett-Connor E; Goodman-Gruen D
    J Bone Miner Res; 1998 Aug; 13(8):1343-9. PubMed ID: 9718204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women.
    Salminen H; Sääf M; Ringertz H; Strender LE
    Osteoporos Int; 2008 Feb; 19(2):201-9. PubMed ID: 17874030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.
    Nabipour I; Larijani B; Beigi S; Jafari SM; Amiri M; Assadi M; Pazoki R; Amiri Z; Sanjdideh Z
    Menopause; 2008; 15(5):934-9. PubMed ID: 18451743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Kanazawa I; Notsu M; Miyake H; Tanaka K; Sugimoto T
    Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older.
    Kim HJ; Koo HS; Kim YS; Kim MJ; Kim KM; Joo NS; Haam JH
    J Bone Miner Metab; 2017 Nov; 35(6):659-665. PubMed ID: 27873076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women.
    Karasik D; Rosen CJ; Hannan MT; Broe KE; Dawson-Hughes B; Gagnon DR; Wilson PW; Visser M; Langlois JA; Mohan S; Kiel DP
    Calcif Tissue Int; 2002 Oct; 71(4):323-8. PubMed ID: 12202958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, sex steroids, osteocalcin and bone mineral density in male and female rats.
    Fukuda R; Usuki S; Mukai N; Amagai H; Hayashi K; Takamatsu K
    Gynecol Endocrinol; 1998 Oct; 12(5):297-305. PubMed ID: 9859021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of obesity and diabetes on rate of bone density loss.
    Leslie WD; Morin SN; Majumdar SR; Lix LM
    Osteoporos Int; 2018 Jan; 29(1):61-67. PubMed ID: 28917003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum 25-hydroxyvitamin D levels do not retard postmenopausal bone loss in Japanese women: the Yokogoshi study.
    Kitamura K; Nakamura K; Saito T; Kobayashi R; Oshiki R; Nishiwaki T; Iwasaki M; Yoshihara A
    Arch Osteoporos; 2013; 8():153. PubMed ID: 24105337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.